Fatty acid-binding protein as the earliest available plasma marker of acute myocardial injury

Journal of Clinical Ligand Assay

Volumn 25, Issue 2, 2002, Pages 167-177

  Glatz, Jan F C ^a   Van der Voort, Danielle ^a   Hermens, Wim T ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Acute coronary syndromes; Fatty acid binding protein; Ischemic injury; Myocardial infarction; Myoglobin; Risk stratification; Unstable angina pectoris

Indexed keywords

BIOCHEMICAL MARKER; CARRIER PROTEIN; FATTY ACID BINDING PROTEIN; MYOGLOBIN;

ACUTE HEART INFARCTION; BLOOD LEVEL; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FATTY ACID TRANSPORT; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HUMAN; KINETICS; MULTICENTER STUDY; PROGNOSIS; PROTEIN SECRETION; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THORAX PAIN; TISSUE SPECIFICITY; UNSTABLE ANGINA PECTORIS;

ANGINA;

EID: 0037633053     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Ryan TJ, Antman EM, Brooks NH, et al: 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations. Circulation 1999;100:1016-1030.
2. Alpert JS, Thygesen K, Antman E, et al: Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
3. Smith SC, Dove JT, Jacobs AK, et al: ACC/AHA guidelines for percutaneous coronary intervention - Executive summary. J Am Coll Cardiol 2001;37:2215-2238.
4. Adams JE, Abendschein DR, Jaffe AS: Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 1993;88:750-763.
5. Christenson RH, Azzazy HME: Biochemical markers of the acute coronary syndromes. Clin Chem 1998;44:1855-1864.
6. Mair J: Progress in myocardial damage detection: New biochemical markers for clinicians. Crit Rev Clin Lab Sci 1997;34:1-66.
7. Glatz JFC, Van Bilsen M, Paulussen RJA, et al: Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta 1988;961:148-152.
8. Glatz JFC, Van der Vusse GJ: Cellular fatty acid-binding proteins. Their function and physiological significance. Prog Lipid Res 1996;35:243-282.
9. Storch J, Thumser EA: The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 2000;1486:28-44.
10. Banaszak L, Winter N, Xu Z, et al: Lipid binding proteins: a family of fatty acid and retinoid transport proteins. Adv Protein Chem 1994;45:89-151.
11. Young AC, Scapin G, Kromminga A, et al: Structural studies on human muscle fatty acid binding protein at 1.4 A resolution: Binding interactions with three C18 fatty acids. Structure 1994;2:523-534.
12. Schreiber A, Specht B, Pelsers MMAL, et al: Recombinant human heart-type fatty acid-binding protein as standard in immunochemical assays. Clin Chem Lab Med 1998;36:283-288.
13. Kragten JA, Van Nieuwenhoven FA, Van Dieijen-Visser MP, et al: Distribution of myoglobin and fatty acid-binding protein in human cardiac autopsies. Clin Chem 1996;42:337-338.
14. Van Nieuwenhoven FA, Kleine AH, Wodzig KWH, et al: Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995;92:2848-2854.
15. Yoshimoto K, Tanaka T, Somiya K, et al: Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction. Heart Vessels 1995;10:304-309.
16. Van Breda E, Keizer HA, Vork MM, et al: Modulation of fatty acid-binding protein content of rat heart and skeletal muscle by endurance training and testosterone treatment. Eur J Physiol 1992;421:274-279.
17. Glatz JFC, Van Breda E, Keizer HA, et al: Rat heart fatty acid-binding protein content is increased in experimental diabetes. Biochem Biophys Res Commun 1994;199:639-646.
18. Vork MM, Trigault N, Snoeckx LHEH, Glatz JFC, Van der Vusse GJ: Heterogeneous distribution of fatty acid-binding protein in the hearts of Wistar Kyoto and Spontaneously Hypertensive rats. J Mol Cell Cardiol 1992;24:317-321.
19. Glatz JFC, Storch J: Unraveling the significance of cellular fatty acid-binding proteins. Curr Opinion Lipidol 2001;12:267-274.
20. Schaap FG, Binas B, Danneberg H, et al: Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene. Circ Res 1999;85:329-337.
21. Van der Lee KAJM, Vork MM, De Vries JE, et al: Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. J Lipid Res 2000;41:41-47.
22. Wolfrum C, Borrmann CM, Börchers T, Spener F: Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid-binding protein. Proc Natl Acad Sci USA 2001;98:2323-2328.
23. Wodzig KWH, Pelsers MMAL, Van der Vusse GJ, et al: One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein. Ann Clin Biochem 1997;34:263-268.
24. Tanaka T, Hirota Y, Sohmiya K, et al: Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 1991;24:195-201.
25. Kleine AH, Glatz JFC, Van Nieuwenhoven FA, et al: Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992;116:155-162.
26. Ohkaru Y, Asayama K, Ishii H, et al: Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding protein. J Immunol Meth 1995;178:99-111.
27. Knowlton AA, Burrier RE, Brecher P: Rabbit heart fatty acid-binding protein. Isolation, characterization, and application of a monoclonal antibody. Circ Res 1989;165:981-988.
28. Katrukha A, Bereznikova A, Filatov V, et al: Development of sandwich time-resolved immunofluorometric assay for the quantitative determination of fatty acid-binding protein (FABP). Clin Chem 1997;43:S106(abstract).
29. Roos W, Eymann E, Symannek M, et al: Monoclonal antibodies to human heart fatty acid-binding protein. J Immunol Meth 1995;183:149-153.
30. Robers M, Van der Hulst FF, Fischer MAJG, et al: Development of a rapid microparticle-enhanced turbidimetric immunoassay for plasma fatty acid-binding protein, an early marker of acute myocardial infarction. Clin Chem 1998;44:1564-1567.
31. Sanders GT, Schouten Y, De Winter RJ, et al: Evaluation of human heart type fatty acid-binding protein assay for early detection of myocardial infarction. Clin Chem 1998;44:A132(abstract).
32. Ghani F, Wu AHB, Graff L, et al: Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 2000;46:718-719.
33. Siegmann-Thoss C, Renneberg R, Glatz JFC, et al: Enzyme immunosensor for diagnosis of myocardial infarction. Sensors Actuators 1996;B30:71-76.
34. Schreiber A, Feldbrügge R, Key G, et al: An immunosensor based on disposable electrodes for rapid estimation of fatty acid-binding protein, an early marker of myocardial infarction. Biosens Bioelectr 1997;12:1131-1137.
35. Renneberg R, Cheng S, Kaptein WA, et al: Novel immunosensors for rapid diagnosis of acute myocardial infarction: a case report. Adv Biosens 1999;4:241-272.
36. Key G, Schreiber A, Feldbrügge R, et al: Multicenter evaluation of an amperometric immunosensor for plasma fatty acid-binding protein: an early marker for acute myocardial infarction. Clin Biochem 1999;32:229-231.
37. Robers M, Rensink IJAM, Hack CE, et al: A new principle for rapid immunoassay of proteins based on in situ precipitate-enhanced ellipsometry. Biophys J 1999;76:2769-2776.
38. Watanabe T, Ohkubo Y, Matsuoka H, et al: Development of a simple whole blood panel test for detection of human heart-type fatty acid-binding protein. Clin Biochem 2001;34:257-263.
39. Tsuji R, Tanaka T, Sohmiya K, et al: Human heart-type cytoplasmic fatty acid-binding protein in serum and urine during hyperacute myocardial infarction. Int J Cardiol 1993;41:209-217.
40. Hermens WT, Pelsers MMAL, Mullers-Boumans ML, et al: Combined use of markers of muscle necrosis and fibrinogen conversion in the early differentiation of myocardial infarction and unstable angina. Clin Chem 1998;44:890-892.
41. Wodzig KWH, Kragten JA, Hermens WT, et al: Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein. Influence of renal function. Eur J Clin Chem Clin Biochem 1997;35:191-198.
42. De Groot MJM, Wodzig KWH, Simoons ML, et al: Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates. Cardiovasc Res 1999;44:315-324.
43. Kragten JA, Hermens WT, Van Dieijen-Visser MP: Cardiac troponin T release into plasma after acute myocardial infarction: Only fractional recovery compared with enzymes. Ann Clin Biochem 1996;33:314-223.
44. Hermens WT: Mechanisms of protein release from injured heart muscle. Dev Cardiovasc Med 1998;205:85-98.
45. Van Nieuwenhoven FA, Musters RJP, Post JA, et al: Release of proteins from isolated neonatal rat cardiac myocytes subjected to simulated ischemia or metabolic inhibition is independent of molecular mass. J Mol Cell Cardiol 1996;28:1429-1434.
46. Katrukha AG, Bereznikova AV, Esakova TV, et al: Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 1997;43:1379-1385.
47. McDonough JL, Arrell DK, Van Eyk JE: Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res 1999;84:9-20.
48. Górski J, Hermens WT, Borawski J, et al: Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure. Clin Chem 1997;43:193-195.
49. Nayashida N, Chihara S, Tayama E, et al: Influence of renal function on serum and urinary heart fatty acid-binding protein levels. J Cardiovasc Surg 2001;42:735-740.
50. Ishii J, Wang JH, Naruse H, et al: Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997;43:1372-1378.
51. Glatz JFC, Van der Vusse GJ, Simoons M, et al: Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 1998;272:87-92.
52. Pelsers MMAL, Chapelle JP, Knapen M, et al: Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects. Clin Chem 1999;45:441-443.
53. Glatz JFC, Haastrup B, Hermens WT, et al: Fatty acid-binding protein and the early detction of acute myocardial infarction: the EUROCARDI multicenter trial. Circulation 1997;96:I-215(abstract).
54. Kristensen SR, Haastrup B, Hørder M, et al: Fatty acid-binding protein: a new early marker of AMI. Scand J Clin Lab Invest 1996;56(suppl)225:36-37 (abstract).
55. Okamoto F, Sohmiya K, Ohkaru Y, et al: Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med 2000;38:231-238.
56. Panteghini M, Bonora R, Pagani F, et al: Heart fatty acid-binding protein in comparison with myoglobin for the early detection of acute myocardial infarction. Clin Chem 1997;43:S157(abstract).
57. Abe S, Saigo M, Yamashita T, et al: Heart fatty acid-binding protein is useful in early and myocardial-specific diagnosis of acute myocardial infarction. Circulation 1996;94:I-323(abstract).
58. Hamm CW, Ravkilde J, Gerhardt W, et al: The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146-150.
59. Ravkilde J, Hørder M, Gerhardt W: Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. Scand J Clin Lab Invest 1993;53:677-683.
60. Katrukha A, Bereznekiva A, Filatov V, et al: Improved detection of minor ischemic cardiac injury in patients with unstable angina by measurement of cTnI and fatty acid binding protein (FABP). Clin Chem 1999;45:A139(abstract).
61. Fransen EJ, Maessen JG, Hermens WT, et al: Demonstration of ischaemia-reperfusion injury separate from postoperative infarction in CABG patients. Ann Thoracic Surg 1998;65:48-53.
62. Hayashida N, Chihara S, Akasu K, et al: Plasma and urinary levels of heart fatty acid-binding protein in patients undergoing cardiac surgery. Jpn Circ J 2000;64:18-22.
63. Petzold T, Feindt P, Sunderdiek U, et al: Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting. Eur J Cardiothor Surg 2001;19:859-864.
64. Glatz JFC, Kleine AH, Van Nieuwenhoven FA, et al: Fatty acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans. Br Heart J 1994;71:135-140.
65. Hermens WT, Van der Veen FH, Willems GM, et al: Complete recovery in plasma of enzymes lost from the heart after permanent coronary occlusion in the dog. Circulation 1990;81:649-659.
66. Van der Laarse A: Rapid estimation of myocardial infarct size. Cardiovasc Res 1999;44:247-248.
67. Ishii J, Nagamura Y, Nomura M, et al: Early detection of successful coronary reperfusion based on serum concentration of human heart-type cytoplasmic fatty acid-binding protein. Clin Chim Acta 1997;262:13-27.
68. De Lemos JA, Antman EM, Morrow D, et al: Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy. Clin Chim Acta 2000;298:85-97.
69. De Groot MJM, Muijtjens AMM, Simoons ML, et al: Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma. Heart 2001;85:278-285.
70. Setsuta K, Arao M, Miyatake Y, Imai T: Elevated levels of heart type fatty acid binding protein in patients with chronic heart failure. Circulation 1999;100:I-649(abstract).
71. Komamura K, Ohkaru Y, Asayama K, et al: Heart-type fatty acid binding protein: An important predictor of cardiac events in heart failure. J Card Fail 1999;5(Suppl 1):19(abstract).
72. Missov E, Mair J: A novel biochemical approach to congestive heart failure: Cardiac troponin T. Am Heart J 1999;138:95-99.
73. Kleine AH, Glatz JFC, Havenith MG, et al: Immunohistochemical detection of very recent myocardial infarctions in man with antibodies against heart type fatty acid-binding protein. Cardiovasc Pathol 1993;2:63-69.
74. Watanabe K, Wakabayashi H, Veerkamp JH, et al: Immunohistochemical distribution of heart-type fatty acid-binding protein immunoreactivity in normal human tissues and in acute myocardial infarct. J Pathol 1993;170:59-65.
75. Ortmann C, Pfeiffer H, Brinkmann B: A comparative study on the immunohistochemical detection of early myocardial damage. Int J Legal Med 2000;113:215-220.
76. Fesmire FM: Delta CK-MB outperforms delta troponin I at 2 hours during the ED rule out of acute myocardial infarction. Am J Emerg Med 2000;18:1-8.
77. De Winter RJ, Bholasingh R, Nieuwenhuijs AB, et al: Ruling out acute myocardial infarction early with two serial creatine kinase-MB mass determinations. Eur Heart J 1999;20:967-972.
78. Noble MIM: Can negative results for protein markers of myocardial damage justify discharge of acute chest pain patients after a few hours in hospital? Eur Heart J 1999;20:925-927.
79. Haastrup B: Application of biochemical markers for early diagnosis and treatment in acute myocardial ischemia. PhD thesis, University of Southern Denmark, Odense, 2000.
80. Haastrup B, Gill S, Kristensen SR, et al: Biochemical markers of ischaemia for the early identification of acute myocardial infarction without ST segment elevation. Cardiology 2000;94:254-261.
81. Jesse RL, Kontos MC: Evaluation of chest pain in the emergency department. Curr Problems Cardiol 1997;22:149-236.
82. Merlini PA, Bauer KA, Oltrona L, et al: Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994;90:61-68.
83. Carville DGM, Dimitrijevic N, Walsh M, et al: Thrombus precursor protein (TpP): Marker of thrombosis early in the pathogenesis of myocardial infarction. Clin Chem 1996;42:1537-1541.
84. Kaptein WA, Zwaagstra JJ, Venema K, Korf J: Continuous ultrasolw microdialysis and ultrafilrtration for subcutaneous sampling as demonstrated by glucose and lactate measurements in rats. Anal Chem 1998;70:4696-4700.
85. Kaptein WA, Korf J, Cheng S, et al: On-line flow displacement immunoassay for fatty acid-binding protein. J Immunol Meth 1998;217:103-111.
86. Wu AHB, Apple FA, Gibler WB, et al: National Academy of Clinical Biochemistry Standards on Laboratory Practice: Recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104-1121.
87. Panteghini M, Apple FS, Christenson RH, et al: Use of biochemical markers in acute coronary syndromes. 1FCC Scientific Division, Committee on Standardization of markers of Cardiac Damage. Clin Chem Lab Med 1999;37:687-693.
88. Storrow AB, Gibler WB: The role of cardiac markers in the emergency department. Clin Chim Acta 1999;284:187-196.
89. Wu AH: Analytical and clinical evaluation of new diagnostic tests for myocardial damage. Clin Chim Acta 1998;272:11-21.